Is it worth screening for vancomycin-resistant Enterococcus faecium colonization?: Financial burden of screening in a developing country

Ulu-Kilic A., Ozhan E., Altun D., Percin D., GÜNEŞ T., Alp E.

AMERICAN JOURNAL OF INFECTION CONTROL, vol.44, no.4, 2016 (SCI-Expanded) identifier identifier identifier


Background: The screening of critically ill patients at high risk of vancomycin resistant enterococci (VRE) colonization, to detect and isolate colonized patients, is recommended to prevent and control the transmission of VRE. Screening asymptomatic carriers brings financial burden for institutions. In this study, we performed risk analysis for VRE colonization and determined the financial burden of screening in a middle-income country, Turkey.